home / stock / rlftf / rlftf news

RLFTF News and Press, Mondobiotech Holding AG Basel

Stock Information
Company Name: Mondobiotech Holding AG Basel
Stock Symbol: RLFTF
Market: OTC
Website: relieftherapeutics.com
Menu
RLFTF RLFTF Quote RLFTF Short RLFTF News RLFTF Articles RLFTF Message Board
Get RLFTF Alerts

News, Short Squeeze, Breakout and More Instantly...
RLFTF - RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting

GENEVA, SWITZERLAND / ACCESSWIRE / June 27, 2024 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, ann...
RLFTF - Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders

GENEVA, SWITZARLAND / ACCESSWIRE / May 30, 2024 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select rare diseases, today announced the Annual General Mee...

RLFTF - Relief Therapeutics makes key management changes

2024-05-08 05:46:00 ET More on Relief Therapeutics Financial information for Relief Therapeutics Holding SA Read the full article on Seeking Alpha For further details see: Relief Therapeutics makes key management changes

RLFTF - Relief Therapeutics Announces New Executive Leadership Team Strengthening Capabilities to Guide the Company through Pipeline Development Initiatives

GENEVA, SWITZERLAND / ACCESSWIRE / May 8, 2024 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select rare diseases, today announced the formation of its ne...
RLFTF - Relief Therapeutics has Published its Annual Report

GENEVA, SWITZARLAND / ACCESSWIRE / April 30, 2024 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today published its Annual Repo...

RLFTF - Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE

GENEVA, SWITZERLAND / ACCESSWIRE / March 22, 2024 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announce...

RLFTF - Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria

PKU GOLIKE® is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call point Transaction is expected to be accretive to 2024 earnings Estimated peak sales of more than $10 million annually U.S. phenylketonuria ("PKU"...
RLFTF - Relief Therapeutics Renews CHF 50 million Share Subscription Facility

3-year CHF 50 million capital commitment from GEM Relief advances strategic transformation GENEVA, SWITZERLAND / ACCESSWIRE / February 28, 2024 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief, or the Company), a biopharmaceutical company committed t...

RLFTF - Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth

GENEVA, SWITZERLAND / ACCESSWIRE / December 5, 2023 / RELIEF THERAPEUTICS Holding SA (SIX: RLF )(OTCQB: RLFTF )(OTCQB: RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering innovative treatment options for select specialty, unmet and rare diseases, today announc...

RLFTF - Relief Therapeutics announces CEO transition

2023-11-22 03:21:24 ET More on Relief Therapeutics Holding AG Financial information for Relief Therapeutics Holding AG For further details see: Relief Therapeutics announces CEO transition
Next 10